February 23-25, 2023 | New York Hilton, NY

Nestlé Health Science: Unlocking Cellular Potential – Key Nutrients to Revitalize Mitochondrial Health

Sponsored Lunch and Learn Presentation*
11:30PM – 1:00 PM | Friday, February 18, 2022

Session Description: Join Nestlé Health Science, the makers of Celltrient™ Cellular Nutrition, for a conversation with experts in the field of nutrition and aging. Leaders will discuss clinical research on emerging nutritional interventions targeting mitochondrial function and overall cellular health, as well as the potential impact of these nutrients on healthspan and quality of life. Take away new learnings and resources to support your clients in revolutionizing the way we age with nutrition.

Objectives: 

• Summarize the cellular changes associated with biological aging and functional declines
• Review the latest clinical evidence on targeted nutritional interventions supporting cellular health, including Nicotinamide Riboside, Urolithin A, and GlyNAC
• Discuss the application of these interventions in clinical practice and the potential to improve healthspan

*Denotes a Non-CME activity.

About the Speakers: Nathan Morris, MD; Stuart Phillips, PhD, FACSM, FCAHS; Charles Brenner, PhD 

NATHAN MORRIS, MD:

Nathan Morris is the Chief Medical Officer of Atrium Innovations Pro Brands. He resides in Monument, CO where he has a multidisciplinary functional medicine practice, Good Medicine, which focuses on making the complex simple.

Dr. Morris is certified by the Institute for Functional Medicine and has practiced root cause medicine for well over a decade. He is actively involved in the evolution of PureGenomics®, which he envisioned and co-created with Kelly Heim, Ph.D. He is also a partner with MBN Systems, which supports the implementation of systems based medical training in medical schools and residencies. He also a co-hosts for the podcast, “Good Medicine on the Go” where he explores personalization, technology, and practice implementation strategies. His most recent season explores the history, mechanism of action, and clinical application of cannabis.

Dr. Morris is excited about the future of medicine as he helps create the future of personalization and its evolution as it empowers patients to understand their uniqueness and strengths.

STUART PHILLIPS, PHD, FACSM, FCAHS

Stuart Phillips is a full Professor in the Department of Kinesiology and a member of the School of Medicine at McMaster University. He is Tier 1 Canada Research Chair in Skeletal Muscle Health. He is also the Director of the McMaster University Physical Activity Centre of Excellence. Dr. Phillips has authored more than 250 original research papers and 90 reviews. In 2018-21 he was named to Clarivate’s Highly Cited Researchers list as a being in the top 1% of all cited researchers in nutrition and physiology research. Dr. Phillips is a fellow of the American College of Sports Medicine and the Canadian Academy of Health Sciences.

 

 

 

 

 

CHARLES BRENNER, PHD

Charles Brenner is a 1983 graduate of Wesleyan University, who trained for 5 years at Chiron Corporation and DNAX Research Institute prior to earning his PhD at Stanford University in 1993. After serving as a Leukemia Society of America post-doctoral fellowship at Brandeis University, he took his first independent position at Thomas Jefferson University in 1996. Recruited to Dartmouth in 2003, Dr. Brenner turned his attention to the synthesis and functions of nicotinamide adenine dinucleotide (NAD), the central catalyst of metabolism. After rising to full professor at Dartmouth, Dr. Brenner was recruited to University of Iowa in 2009, where he served as the Roy J. Carver Head of Biochemistry. In 2020, Dr. Brenner was recruited to City of Hope to serve as the inaugural Alfred E. Mann Chair of the new Department of Diabetes & Cancer Metabolism. Highlights of Dr. Brenner’s career include discovery of nicotinamide riboside (NR) as a vitamin and characterization of the NR kinase pathway, development of targeted NAD metabolomics and characterization of multiple conditions of metabolic stress that disturb the NAD system including heart failure, peripheral and central neurodegeneration, cancer, obesity, diabetes, coronavirus infection and postpartum. Dr. Brenner participated in several of the first clinical trials of NR. Moreover, his mechanistic work in model systems has led to clinical trials of NR globally. Dr. Brenner’s intellectual property on NR was commercialized and developed by ChromaDex, for whom he serves as chief scientific advisor. Dr. Brenner is also a leading voice in science communication, who attempts to explain metabolism to the lay public and that though we do have to age, we can age better. He lives in Pasadena, California with a wise-cracking marathon runner and a rescue dog

Register Today!

 

© Diversified Communications. All rights reserved.